Last reviewed · How we verify
NCT06372938
Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach
trial testing Ultrasound measurement in Fetal Growth Restriction in 240 participants. Participants enrolled and being followed up; not accepting new ones.
6 July 2024
Quick facts
| Lead sponsor | Ankara Etlik City Hospital |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 240 |
| Start date | 31 January 2024 |
| Primary completion | 6 July 2024 |
| Estimated completion | 20 July 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Ultrasound measurement
- Laboratory Tests and Inflammatory Markers
Conditions studied
- Fetal Growth Restriction — all drugs for Fetal Growth Restriction →
- Inflammatory Response — all drugs for Inflammatory Response →
Sponsor
Ankara Etlik City Hospital
Who can join
Adults 18 to 45, female only, with Fetal Growth Restriction or Inflammatory Response. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Fetal growth restriction (FGR) is a serious complication in pregnancy that can lead to various adverse outcomes. It's classified into early-onset (before 32 weeks) and late-onset (after 32 weeks), with late-onset associated with long-term risks like hypoxemia and developmental delays. The study focuses on the role of inflammation in FGR, introducing new blood markers for better understanding and diagnosis. It also addresses the challenges of using advanced diagnostic tools in low-resource settings and explores the use of machine learning to predict FGR based on inflammatory markers, highlighting the potential of artificial intelligence in overcoming these challenges.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine-Learning Approach.
Ulusoy CO, Kurt A, Seyhanli Z, Hizli B, et al · · 2024 · cited 3× · PMID 39422068 · DOI 10.1111/aji.70004
Verify or expand the search:
- PubMed search for NCT06372938
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ultrasound measurement
Trials testing the same drug.
- NCT06997380 — Evaluation of the Safety and Efficacy of an Injectable Liposomal Gel · NA · enrolling by invitation
- NCT07470684 — Skin Involvement in Dupuytren Surgical Treatment Outcome · NA · recruiting
- NCT06321991 — Nodular Shrinking in Dupuytren Disease · Phase 2 · recruiting
- NCT04997655 — The Effect of Upper Transabdominal Plain Block on Diaphragm Thickness · completed
- NCT04842773 — Ultrasound (US) Measurement of Sarcopenia in the Elder Subject · NA · completed
Other recruiting trials for Fetal Growth Restriction
Currently open trials in the same condition.
- NCT06919692 — Maternal Left Lateral Position in Fetal Growth Restriction · NA · recruiting
- NCT07015203 — The Combined First Trimester Screening · recruiting
- NCT06497959 — Study of Placental Vascularization Using Contrast Ultrasound · Phase 3 · recruiting
- NCT05674487 — Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN) · NA · recruiting
- NCT05934318 — L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) · NA · recruiting
Other Ankara Etlik City Hospital trials
Trials by the same sponsor.
- NCT07472452 — MULTIMODAL APPROACH IN THE DIAGNOSIS OF SEPTIC AKI · not yet recruiting
- NCT07488442 — Efficacy of Cognitive Behavioral Therapy Administered in Patients With Dyssynergic Defecation · NA · recruiting
- NCT07488455 — Effectiveness of Video-Based or Written Pelvic Floor Education in Postpartum Women · NA · recruiting
- NCT07375173 — ORI-Guided FiO₂ Titration in Prone Spine Surgery: Impact on Postoperative Atelectasis Assessed by Lung Ultrasound · NA · not yet recruiting
- NCT07456202 — Menstrual Status, Anesthetic Consumption, and PONV · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06372938 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Etlik City Hospital
- Last refreshed: 8 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06372938.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing